Syncona Limited

Research Syncona Limited (SYNC) on Bullrun: market cap GBX 74.93B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is GBX 74.93B.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2026GBP 55.89M-GBP 8.81MGBP 23.33Mn/a-0.01GBP 1.92Mn/aGBP 1.04B
FY2025-GBP 68.31M-GBP 143.16MGBP 43.92Mn/a-0.22GBP 1.11Mn/aGBP 1.05B
FY2024GBP 63.75MGBP 3.79MGBP 20.47Mn/a0.01GBP 261.00Kn/aGBP 1.24B
FY2023-GBP 23.98M-GBP 56.02M-GBP 265.00Kn/a-0.08GBP 11.00Kn/aGBP 1.25B
FY2022GBP 33.70MGBP 8.84MGBP 262.00Kn/a0.01GBP 276.00Kn/aGBP 1.31B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-12GBX 74.93Bn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 GBX.

About Syncona Limited

Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe.

Related stock research

Other Financial Services stocks

Frequently asked questions

What is Syncona Limited's market cap?

Syncona Limited's market capitalization is GBX 74.93B.

What does Syncona Limited do?

Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe.